Reference health

Macrocycles as protein–protein interaction inhibitors

https://doi.org/10.1042/bcj20160619

111/111 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

The 111 checked references that resolve

resolves10.1038/nmeth.1280

An empirical framework for binary interactome mapping

resolves10.1038/nrd.2016.29

Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

resolves10.1016/j.drudis.2014.08.005

Stabilization of protein–protein interactions by small molecules

resolves10.1016/j.chembiol.2014.09.001

Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality

resolves10.1016/0092-8674(95)90406-9

Modular binding domains in signal transduction proteins

resolves10.1074/jbc.R100065200

PDZ Domains: Structural Modules for Protein Complex Assembly

resolves10.1016/0092-8674(93)90405-F

Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms

resolves10.1016/S0092-8674(00)81307-0

Crystal Structures of a Complexed and Peptide-Free Membrane Protein–Binding Domain: Molecular Basis of Peptide Recognition by PDZ

resolves10.1038/382649a0

Crystal structure of a PDZ domain

resolves10.1126/science.274.5289.948

Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

resolves10.1126/science.275.5302.983

Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis

resolves10.1016/S0092-8674(00)81717-1

The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen

resolves10.1039/C4MD00131A

Towards understanding cell penetration by stapled peptides

resolves10.1038/nchembio.2153

Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices

resolves10.1073/pnas.1303002110

Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy

resolves10.1021/jm4011675

Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress

resolves10.1021/cb501020r

Hydrocarbon Stapled Peptides as Modulators of Biological Function

resolves10.1021/ja405108p

In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide

resolves10.1021/acschembio.6b00486

Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein–Protein Interaction

resolves10.1016/j.ejmech.2014.03.011

Disulfide-rich macrocyclic peptides as templates in drug design

resolves10.1038/nrd1343

Small-molecule inhibitors of protein–protein interactions: progressing towards the dream

resolves10.1038/nbt1127

Engineering novel binding proteins from nonimmunoglobulin domains

resolves10.1021/jm1012374

Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery

resolves10.4155/fmc.12.93

Macrocycles In New Drug Discovery

resolves10.1038/nchembio.1584

How proteins bind macrocycles

resolves10.1021/acs.jmedchem.5b01286

How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets

resolves10.1038/nrd2590

The exploration of macrocycles for drug discovery — an underexploited structural class

resolves10.1021/np200906s

Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010

resolves10.1016/j.chembiol.2014.08.013

Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates

resolves10.2174/1568026611313070005

Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective

resolves10.1126/science.4001944

Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion Surface

resolves10.1002/pmic.200500606

T7 lytic phage‐displayed peptide libraries exhibit less sequence bias than M13 filamentous phage‐displayed peptide libraries

resolves10.1016/j.jviromet.2006.09.017

Bacteriophage T4 nanoparticle capsid surface SOC and HOC bipartite display with enhanced classical swine fever virus immunogenicity: A powerful immunological approach

resolves10.1016/S0022-2836(02)00851-3

Searching for DNA–protein Interactions by Lambda Phage Display

resolves10.1126/science.287.5456.1279

Convergent Solutions to Binding at a Protein-Protein Interface

resolves10.1038/nchembio.184

Phage-encoded combinatorial chemical libraries based on bicyclic peptides

resolves10.1073/pnas.1412152111

Peptide and small molecule inhibitors of HECT-type ubiquitin ligases

resolves10.1021/ja045673m

A Phage Display System with Unnatural Amino Acids

resolves10.1016/j.tetlet.2008.11.094

Thiol-ene reactions of 1,3,5-triacryloylhexahydro-1,3,5-triazine (TAT): facile access to functional tripodal thioethers

resolves10.1002/cbic.201200049

Structurally Diverse Cyclisation Linkers Impose Different Backbone Conformations in Bicyclic Peptides

resolves10.1039/c4cc00811a

Construction of a crown ether-like supramolecular library by conjugation of genetically-encoded peptide linkers displayed on bacteriophage T7

resolves10.1021/cb4006722

Discovery of Light-Responsive Ligands through Screening of a Light-Responsive Genetically Encoded Library

resolves10.1073/pnas.94.23.12297

RNA-peptide fusions for the in vitro selection of peptides and proteins

resolves10.1021/ja301017y

In Vitro Selection of Highly Modified Cyclic Peptides That Act as Tight Binding Inhibitors

resolves10.1021/ja054373h

A General Route for Post-Translational Cyclization of mRNA Display Libraries

resolves10.1038/nprot.2011.331

Flexizymes for genetic code reprogramming

resolves10.1039/c2ob25306b

Selective thioether macrocyclization of peptides having the N-terminal 2-chloroacetyl group and competing two or three cysteine residues in translation

resolves10.1016/j.chembiol.2011.09.013

Natural Product-Like Macrocyclic N-Methyl-Peptide Inhibitors against a Ubiquitin Ligase Uncovered from a Ribosome-Expressed De Novo Library

resolves10.1126/science.2146742

Protein Splicing Converts the Yeast TFP1 Gene Product to the 69-kdDSubunit of the Vacuolar H + -Adenosine Triphosphatase

resolves10.1073/pnas.95.16.9226

Protein trans -splicing by a split intein encoded in a split DnaE gene of Synechocystis sp. PCC6803

resolves10.1073/pnas.96.24.13638

Production of cyclic peptides and proteins in vivo

resolves10.1073/pnas.93.19.10315

Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions.

resolves10.1073/pnas.0406999101

A systematic method for identifying small-molecule modulators of protein–protein interactions

resolves10.1002/anie.200500417

Genetically Selected Cyclic‐Peptide Inhibitors of AICAR Transformylase Homodimerization

resolves10.1073/pnas.1108045108

Evolution of cyclic peptide protease inhibitors

resolves10.1074/jbc.M206162200

Retrovirally Delivered Random Cyclic Peptide Libraries Yield Inhibitors of Interleukin-4 Signaling in Human B Cells

resolves10.1021/ja402993u

A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells

resolves10.1039/c3sc50481f

A cyclic peptide inhibitor of C-terminal binding protein dimerization links metabolism with mitotic fidelity in breast cancer cells

resolves10.1126/science.1102629

DNA-Templated Organic Synthesis and Selection of a Library of Macrocycles

resolves10.1021/jm501892g

The Discovery of Macrocyclic XIAP Antagonists from a DNA-Programmed Chemistry Library, and Their Optimization To Give Lead Compounds with in Vivo Antitumor Activity

resolves10.1371/journal.pbio.0020173

DNA Display I. Sequence-Encoded Routing of DNA Populations

resolves10.1371/journal.pbio.0020174

DNA Display II. Genetic Manipulation of Combinatorial Chemistry Libraries for Small-Molecule Evolution

resolves10.1038/nbt961

Encoded self-assembling chemical libraries

resolves10.1073/pnas.0805130105

High-throughput sequencing allows the identification of binding molecules isolated from DNA-encoded chemical libraries

resolves10.1126/science.287.5460.1964

Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery

resolves10.1021/jm0606600

Discovery of a New Class of Macrocyclic Antagonists to the Human Motilin Receptor

resolves10.1016/j.bmcl.2007.05.043

Potent macrocyclic antagonists to the motilin receptor presenting novel unnatural amino acids

resolves10.1021/jm2007062

Optimization of the Potency and Pharmacokinetic Properties of a Macrocyclic Ghrelin Receptor Agonist (Part I): Development of Ulimorelin (TZP-101) from Hit to Clinic

resolves10.1016/j.bmcl.2009.09.089

Syntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic Hedgehog

resolves10.1038/nchem.1729

A strategy for the diversity-oriented synthesis of macrocyclic scaffolds using multidimensional coupling

resolves10.1055/s-0035-1561414

Diversity-Oriented Synthesis of Macrocycle Libraries for Drug Discovery and Chemical Biology

resolves10.1038/354082a0

A new type of synthetic peptide library for identifying ligand-binding activity

resolves10.1038/354084a0

Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery

resolves10.1021/acscombsci.5b00090

Optimization of the Magnetic Recovery of Hits from One-Bead–One-Compound Library Screens

resolves10.1021/ja063722k

High-Throughput Sequence Determination of Cyclic Peptide Library Members by Partial Edman Degradation/Mass Spectrometry

resolves10.1126/science.8211132

Protein Ladder Sequencing

resolves10.1021/cc000102l

Rapid Sequencing of Library-Derived Peptides by Partial Edman Degradation and Mass Spectrometry

resolves10.1021/cb200450w

Cyclic Peptide Inhibitors of HIV-1 Capsid-Human Lysyl-tRNA Synthetase Interaction

resolves10.1039/C2MD20329D

Inhibition of Ras–effector interactions by cyclic peptides

resolves10.1021/ja405106u

Screening Bicyclic Peptide Libraries for Protein–Protein Interaction Inhibitors: Discovery of a Tumor Necrosis Factor-α Antagonist

resolves10.1002/anie.201502763

Inhibition of Ras Signaling by Blocking Ras–Effector Interactions with Cyclic Peptides

resolves10.1016/j.tet.2014.05.113

Direct Ras inhibitors identified from a structurally rigidified bicyclic peptide library

resolves10.1016/S0169-409X(00)00129-0

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

resolves10.1002/bdd.476

The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat

resolves10.1021/acs.jmedchem.5b00919

Going Out on a Limb: Delineating The Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of Sanguinamide A Analogues

resolves10.1021/ja303200d

Intestinal Permeability of Cyclic Peptides: Common Key Backbone Motifs Identified

resolves10.1021/acs.jcim.6b00251

Kinetic Models of Cyclosporin A in Polar and Apolar Environments Reveal Multiple Congruent Conformational States

resolves10.1016/j.addr.2016.03.013

Cell permeability beyond the rule of 5

resolves10.4155/fmc.15.78

Beyond Cyclosporine A: Conformation-Dependent Passive Membrane Permeabilities of Cyclic Peptide Natural Products

resolves10.1021/jm070836d

Effect of Structural and Conformation Modifications, Including Backbone Cyclization, of Hydrophilic Hexapeptides on Their Intestinal Permeability and Enzymatic Stability

resolves10.1016/j.bmc.2014.11.034

Improving the passive permeability of macrocyclic peptides: Balancing permeability with other physicochemical properties

resolves10.1021/ml500239m

EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic Peptides

resolves10.1002/anie.201405364

Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable

resolves10.1038/nchembio.664

On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds

resolves10.1039/C5MB00308C

Synthesis of a large library of macrocyclic peptides containing multiple and diverse N -alkylated residues

resolves10.1016/j.febslet.2013.04.031

Cell‐penetrating peptides: 20 years later, where do we stand?

resolves10.1093/database/bas015

CPPsite: a curated database of cell penetrating peptides

resolves10.1074/jbc.M209548200

Cell-penetrating Peptides

resolves10.1021/cc700185g

Cyclic Peptidyl Inhibitors of Grb2 and Tensin SH2 Domains Identified from Combinatorial Libraries

resolves10.1038/mt.2012.132

Phage Display-directed Discovery of LEDGF/p75 Binding Cyclic Peptide Inhibitors of HIV Replication

resolves10.1021/ja510391n

Fluorescence Correlation Spectroscopy Reveals Highly Efficient Cytosolic Delivery of Certain Penta-Arg Proteins and Stapled Peptides

resolves10.1021/jm901778v

Membrane Permeable Cyclic Peptidyl Inhibitors against Human Peptidylprolyl Isomerase Pin1

resolves10.1038/ncomms1459

Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides

resolves10.1002/anie.201102572

Cell‐Penetrating Homochiral Cyclic Peptides as Nuclear‐Targeting Molecular Transporters

resolves10.1021/bi5004102

Early Endosomal Escape of a Cyclic Cell-Penetrating Peptide Allows Effective Cytosolic Cargo Delivery

resolves10.1021/cb3005275

Efficient Delivery of Cyclic Peptides into Mammalian Cells with Short Sequence Motifs

resolves10.1021/acs.biochem.6b00226

Discovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides

resolves10.1021/ja503710n

Cell-Permeable Bicyclic Peptide Inhibitors against Intracellular Proteins

resolves10.1021/acscombsci.5b00164

Discovery of a Direct Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable Bicyclic Peptides

resolves10.1002/anie.201411594

Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity

resolves10.1002/anie.201610888

Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization

What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1042/bcj20160619"><img src="https://citestamp.com/citestamped/10.1042/bcj20160619/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>

[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1042/bcj20160619/badge.svg)](https://citestamp.com/citestamped/10.1042/bcj20160619)